Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Effects of Chemicals: Overview01:27

Effects of Chemicals: Overview

Drugs, encompassing various chemical compounds from natural sources, lab synthesis, or genetic engineering, elicit different biological responses in living organisms. Some of these responses are desirable or therapeutic, while others are undesirable. The primary goal of administering a drug is to achieve a therapeutic effect, that is, to address a specific disease or health condition. Any concurrent effects outside of this therapeutic outcome are considered undesirable. These undesirable...
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal Serum Metabolomic Signatures Related to Integrase Strand Transfer Inhibitors-Associated Weight Gain in Women with HIV Enrolled in the MACS/WIHS Combined Cohort Study.

The Journal of infectious diseases·2026
Same author

Association between plasma concentrations of integrase strand transfer inhibitors and body weight gain in women with HIV.

AIDS (London, England)·2026
Same author

Causes of Death of Women With HIV: Discordance Between Interdisciplinary Primary Care Teams and Death Certificates.

Journal of acquired immune deficiency syndromes (1999)·2026
Same author

Use of Vending Machines to Deliver Oral Rapid HIV Self-Tests to Veterans: Protocol for a Pilot Study.

JMIR research protocols·2026
Same author

Exploring workflows for long-acting antiretroviral therapy administration in community pharmacies.

Journal of the American Pharmacists Association : JAPhA·2025
Same author

High Virologic Suppression and Favorable Profiles of Two-Drug Antiretroviral Regimens in Africa: A Systematic Review of Current Evidence.

Clinical pharmacology and therapeutics·2025
Same journal

Aging and HIV: a conversation with Dr. Glenn Treisman. Interview by Jennifer Heflin.

BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation·2012
Same journal

HIV/HCV coinfection: a new era of treatment.

BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation·2012
Same journal

Rilpivirine and complera: new first-line treatment options.

BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation·2012
Same journal

Becoming a positive parent: reproductive options for people with HIV.

BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation·2012
Same journal

Giving advocates a voice: an update on the U.S. Positive Women's Network. Interview by Jennifer Heflin.

BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation·2012
Same journal

HIV and bone health.

BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation·2012
See all related articles

Related Experiment Video

Updated: May 22, 2026

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting
05:56

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting

Published on: June 21, 2024

Making sense of side effects.

Jennifer Cocohoba1

  • 1School of Pharmacy, University of California, San Francisco, USA.

BETA : Bulletin of Experimental Treatments for AIDS : a Publication of the San Francisco AIDS Foundation
|May 10, 2012
PubMed
Summary
This summary is machine-generated.

Antiretroviral therapy (ART) significantly improves HIV health but many patients hesitate due to lifelong commitment and fear of side effects. Understanding these barriers is crucial for effective HIV treatment adherence.

Related Experiment Videos

Last Updated: May 22, 2026

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting
05:56

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting

Published on: June 21, 2024

Area of Science:

  • Immunology
  • Infectious Diseases
  • Pharmacology

Background:

  • Combination antiretroviral therapy (ART) has transformed HIV/AIDS management since the 1990s, enabling longer and healthier lives for individuals with HIV.
  • Current US guidelines recommend ART initiation for HIV-positive individuals with CD4 counts below 350 cells/mm3 and suggest consideration for those between 350-500 cells/mm3.

Purpose of the Study:

  • To explore the psychological and practical barriers preventing individuals from initiating or adhering to antiretroviral therapy (ART).
  • To identify key factors influencing patient decisions regarding the commencement of HIV treatment.

Main Methods:

  • Qualitative analysis of patient perspectives on ART initiation.
  • Review of current clinical guidelines and patient psychological responses to long-term medication.

Main Results:

  • Despite ART's proven benefits, a significant number of patients struggle with the decision to start treatment.
  • Hesitancy is linked to the prospect of lifelong therapy, medication's association with illness, and a primary fear of adverse side effects.

Conclusions:

  • Addressing patient fears regarding side effects and the lifelong nature of ART is essential for improving treatment adherence.
  • Patient-centered counseling and support are vital to overcome psychological barriers to effective HIV management.